Latest News

Date Title Topic
13 Mar 2017 EMA’s PRAC Concludes Assessment of Gadolinium Agents and Recommends Regulatory Actions, Including Suspension of Some Marketing Authorisations Diagnosis, Imaging and Staging
10 Mar 2017 Use of imatinib in CML has pointed oncology in a new direction Haematologic malignancies - Anticancer agents & Biologic therapy
08 Mar 2017 Clarification of Hepatitis B Virus Status Needed Before Starting Treatment with Pomalidomide Anticancer agents & Biologic therapy
Webcasts
07 Mar 2017 FDA Approves Telotristat Ethyl for Carcinoid Syndrome Diarrhoea Endocrine and neuroendocrine tumours
07 Mar 2017 Press Release: Targeted Anticancer Therapies (TAT) Congress Becomes an Annual ESMO Event
06 Mar 2017 The Polish Translation of our ESMO Patient Guide in Cervical Cancer is Now Available Online
06 Mar 2017 NICE Issues a Quality Standard in Diagnosis, Assessment and Management of Head and Neck Cancer Head and neck cancers
03 Mar 2017 EMA Recommends Granting a Marketing Authorisation for Pemetrexed Hospira UK Limited Lung and other thoracic tumours - Anticancer agents & Biologic therapy
02 Mar 2017 Press Release: Save the Dates for Upcoming ESMO Meetings
02 Mar 2017 EMA Recommends Granting a Marketing Authorisation for Rolapitant Palliative and supportive care
01 Mar 2017 Association Between Gut Microbiome and Responses to Anti-PD-1 Therapy in Patients with Metastatic Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
28 Feb 2017 EMA Recommends Extensions of Indication for Daratumumab Haematologic malignancies - Anticancer agents & Biologic therapy
27 Feb 2017 EMA Recommends Extensions of Indications for Dabrafenib and Trametinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy